Which cancer treatment types are linked to bladder cancer development?

• A. Use of cyclophosphamide
• B. Radiation treatment to abdomen or pelvis
• C. Both
• D. Neither

Answer: (C)

Exposure of the bladder to toxic effects from certain cancer treatments increases the risk of developing bladder cancer. Cyclophosphamide, a common chemotherapy drug, is metabolized into acrolein, a substance that directly irritates and damages the bladder lining. This urothelial injury can lead to malignant transformation, especially with higher cumulative doses. Prophylaxis with agents like mesna and good hydration help reduce acute bladder toxicity, but long-term risk remains a consideration after substantial exposure.

Radiation to the abdomen or pelvis exposes the bladder to ionizing radiation, which can cause DNA damage in bladder cells. Over time, this damage can lead to secondary cancers, including bladder cancer, with latency often measured in years to decades. The risk depends on the radiation dose and the area treated, among other factors.

Because both modalities can affect bladder tissue and contribute to later cancer risk, both cyclophosphamide and pelvic/abdominal radiation are linked to bladder cancer development.